Atovaquone/proguanil

Drug Profile

Atovaquone/proguanil

Alternative Names: Atovaquone and proguanil hydrochloride; Atovaquone/chloroguanide; Malanil; Malarone; Malarone® Paediatric; Proguanil hydrochloride/atovaquone; Proguanil/atovaquone

Latest Information Update: 31 Jul 2014

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator GlaxoSmithKline
  • Class Antimalarials; Biguanides; Naphthoquinones
  • Mechanism of Action Electron transport complex I inhibitors; Tetrahydrofolate dehydrogenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Malaria

Most Recent Events

  • 11 Jun 2013 Launched prior to this date for Malaria in Australia (PO)
  • 11 Jun 2013 Launched prior to this date for Malaria in Chile (PO)
  • 11 Jun 2013 Launched prior to this date for Malaria in Hong Kong (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top